Other languages HilleVax, Inc.

Equities

HLVX

US43157M1027

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-22 pm EDT			5-day change	1st Jan Change
14.14 ^USD	-2.68%		-6.36%	-11.90%

May. 22	Hillevax Insider Sold Shares Worth $266,291, According to a Recent SEC Filing	MT
May. 09	HilleVax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hillevax Insider Sold Shares Worth $266,291, According to a Recent SEC Filing	May. 22
HilleVax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09
Hillevax Insider Sold Shares Worth $264,467, According to a Recent SEC Filing	Apr. 05
HilleVax Insider Sold Shares Worth $985,536,428, According to a Recent SEC Filing	Mar. 21
HilleVax Proposes $500 Million Offering of Equity, Debt Securities in Shelf Registration	Mar. 20
HilleVax Q4 Net Loss Widens; Shares Extend Decline After Hours	Mar. 20
HilleVax, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20
HilleVax, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 20
HilleVax Names New Chief Operating Officer	Jan. 18
HilleVax, Inc. Announces Executive Changes	Jan. 18
Hillevax Insider Sold Shares Worth $287,000, According to a Recent SEC Filing	Dec. 05
Hillevax Insider Sold Shares Worth $140,000, According to a Recent SEC Filing	Nov. 20
HilleVax Q3 Net Loss Widens	Nov. 09
HilleVax, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09
HilleVax Prices $100 Million Common Stock Offering	23-09-20
HilleVax, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
HilleVax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12
HilleVax, Inc. Appoints Nanette Cocero as Board of Director	23-05-09
HilleVax Announces Completion of Enrollment of NEST-IN1 Phase 2b Clinical Study of HIL-214 Norovirus Vaccine Candidate	23-04-25
HilleVax, Inc. Announces Resignation of Susan Silbermann from the Board of Directors	23-04-18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages HilleVax, Inc.

Equities

HLVX

US43157M1027

Other languages

Filters